Cargando…
ODP509 Proof-of-concept, Multicenter, Open-Label Phase 2a Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease
In thyroid eye disease (TED), immunoglobulin G (IgG) autoantibodies target thyrotropin receptors (TSHR) on the thyroid gland causing Graves’ disease. These TSHR-Ab also bind to the TSHR on orbital fibrocytes, inducing inflammation and hyaluronan production, resulting in extraocular muscle swelling a...
Autores principales: | Janes, Jonathan, Kahaly, George, Liang, Su, Tedeschi, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625233/ http://dx.doi.org/10.1210/jendso/bvac150.1609 |
Ejemplares similares
-
RF35 | PSAT269 Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase 2b Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease
por: Kahaly, George, et al.
Publicado: (2022) -
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
por: Kahaly, George J, et al.
Publicado: (2023) -
SAT509 The Clinical Significance of Cribriform Morular Thyroid Carcinoma
por: Soh, Gilbert, et al.
Publicado: (2023) -
ODP475 Developing suppurative thyroiditis
por: Katwal, Dilasha, et al.
Publicado: (2022) -
ODP590 Combined Orbital Irradiation and Systemic Steroids in the Management of Progressive Thyroid Eye Disease
por: Capellan, Maria Leonora, et al.
Publicado: (2022)